
Medtronic PLC (MDT) shares were hit hard today after it was alleged that the CFO of the company issued soft guidance for FY20. However, this allegation has not yet been confirmed, so the potential for a rebound is significant. As of the time this content was created, MDT shares were down over 6% on high volume, which suggests that this allegation is being taken seriously by traders. Here’s a recap.